- •Preface and Acknowledgments
- •Contents
- •Contributors
- •1: Embryology for Urologists
- •Introduction
- •Renal Development
- •Pronephros
- •Mesonephros
- •Metanephros
- •Development of the Collecting System
- •Critical Steps in Further Development
- •Anomalies of the Kidney
- •Renal Agenesis
- •Renal Aplasia
- •Renal Hypoplasia
- •Renal Ectopia
- •Renal Fusion
- •Ureteral Development
- •Anomalies of Origin
- •Anomalies of Number
- •Incomplete Ureteral Duplication
- •Complete Ureteral Duplication
- •Ureteral Ectopia
- •Embryology of Ectopia
- •Clinical Correlation
- •Location of Ectopic Ureteral Orifices – Male (in Descending Order According to Incidence)
- •Symptoms
- •Ureteroceles
- •Congenital Ureteral Obstruction
- •Pipestem Ureter
- •Megaureter-Megacystis Syndrome
- •Prune Belly Syndrome
- •Vascular Ureteral Obstructions
- •Division of the Urogenital Sinus
- •Bladder Development
- •Urachal Anomalies
- •Cloacal Duct Anomalies
- •Other Bladder Anomalies
- •Bladder Diverticula
- •Bladder Extrophy
- •Gonadal Development
- •Testicular Differentiation
- •Ovarian Differentiation
- •Gonadal Anomalies
- •Genital Duct System
- •Disorders of Testicular Function
- •Female Ductal Development
- •Prostatic Urethral Valves
- •Gonadal Duct Anomalies
- •External Genital Development
- •Male External Genital Development
- •Female External Genital Development
- •Anomalies of the External Genitalia
- •References
- •2: Gross and Laparoscopic Anatomy of the Upper Urinary Tract and Retroperitoneum
- •Overview
- •The Kidneys
- •The Renal Vasculature
- •The Renal Collecting System
- •The Ureters
- •Retroperitoneal Lymphatics
- •Retroperitoneal Nerves
- •The Adrenal Glands
- •References
- •3: Gross and Laparoscopic Anatomy of the Lower Urinary Tract and Pelvis
- •Introduction
- •Female Pelvis
- •Male Pelvis
- •Pelvic Floor
- •Urinary Bladder
- •Urethra
- •Male Urethra
- •Female Urethra
- •Sphincter Mechanisms
- •The Bladder Neck Component
- •The Urethral Wall Component
- •The External Urethral Sphincter
- •Summary
- •References
- •4: Anatomy of the Male Reproductive System
- •Testis and Scrotum
- •Spermatogenesis
- •Hormonal Regulation of Spermatogenesis
- •Genetic Regulation of Spermatogenesis
- •Epididymis and Ductus Deferens
- •Accessory Sex Glands
- •Prostate
- •Seminal Vesicles
- •Bulbourethral Glands
- •Penis
- •Erection and Ejaculation
- •References
- •5: Imaging of the Upper Tracts
- •Anatomy of the Upper Tracts and Introduction to Imaging Modalities
- •Introduction
- •Renal Upper Tract Basic Anatomy
- •Modalities Used for Imaging the Upper Tracts
- •Ultrasound
- •Radiation Issues
- •Contrast Issues
- •Renal and Upper Tract Tumors
- •Benign Renal Tumors
- •Transitional Cell Carcinoma
- •Renal Mass Biopsy
- •Renal Stone Disease
- •Ultrasound
- •Plain Radiographs and IVU
- •Renal Cystic Disease
- •Benign Renal Cysts
- •Hereditary Renal Cystic Disease
- •Complex Renal Cysts
- •Renal Trauma
- •References
- •Introduction
- •Pathophysiology
- •Susceptibility and Resistance
- •Epidemiological Breakpoints
- •Clinical Breakpoints
- •Pharmacodynamic Parameters
- •Pharmacokinetic Parameters
- •Fosfomycin
- •Nitrofurantoin
- •Pivmecillinam
- •b-Lactam-Antibiotics
- •Penicillins
- •Cephalosporins
- •Carbapenems
- •Aminoglycosides
- •Fluoroquinolones
- •Trimethoprim, Cotrimoxazole
- •Glycopeptides
- •Linezolid
- •Conclusion
- •References
- •7: An Overview of Renal Physiology
- •Introduction
- •Body Fluid Compartments
- •Regulation of Potassium Balance
- •Regulation of Acid–Base Balance
- •Diuretics
- •Suggested Reading
- •8: Ureteral Physiology and Pharmacology
- •Ureteral Anatomy
- •Modulation of Peristalsis
- •Ureteral Pharmacology
- •Conclusion
- •References
- •Introduction
- •Afferent Signaling Pathways
- •Efferent Signaling
- •Parasympathetic Nerves
- •Sympathetic Nerves
- •Vesico-Spinal-Vesical Micturition Reflex
- •Peripheral Targets
- •Afferent Signaling Mechanisms
- •Urothelium
- •Myocytes
- •Cholinergic Receptors
- •Muscarinic Receptors
- •Nicotinic Receptors
- •Adrenergic Receptors (ARs)
- •a-Adrenoceptors
- •b-Adrenoceptors
- •Transient Receptor Potential (TRP) Receptors
- •Phosphodiesterases (PDEs)
- •CNS Targets
- •Opioid Receptors
- •Serotonin (5-HT) Mechanisms
- •g-Amino Butyric Acid (GABA) Mechanisms
- •Gabapentin
- •Neurokinin and Neurokinin Receptors
- •Summary
- •References
- •10: Pharmacology of Sexual Function
- •Introduction
- •Sexual Desire/Arousal
- •Endocrinology
- •Steroids in the Male
- •Steroids in the Female
- •Neurohormones
- •Neurotransmitters
- •Dopamine
- •Serotonin
- •Pharmacological Strategies
- •CNS Drugs
- •Enzyme-inducing Antiepileptic Drugs
- •Erectile Function
- •Ejaculatory Function
- •Premature Ejaculation
- •Abnormal Ejaculation
- •Conclusions
- •References
- •Epidemiology
- •Calcium-Based Urolithiasis
- •Uric Acid Urolithiasis
- •Infectious Urolithiasis
- •Cystine-Based Urolithiasis
- •Aims
- •Who Deserves Metabolic Evaluation?
- •Metabolic Workup for Stone Producers
- •Medical History and Physical Examination
- •Stone Analysis
- •Serum Chemistry
- •Urine Evaluation
- •Urine Cultures
- •Urinalysis
- •Twenty-Four Hour Urine Collections
- •Radiologic Imaging
- •Medical Management
- •Conservative Management
- •Increased Fluid Intake
- •Citrus Juices
- •Dietary Restrictions
- •Restricted Oxalate Diet
- •Conservative Measures
- •Selective Medical Therapy
- •Absorptive Hypercalciuria
- •Thiazide
- •Orthophosphate
- •Renal Hypercalciuria
- •Primary Hyperparathyroidism
- •Hyperuricosuric Calcium Oxalate Nephrolithiasis
- •Enteric Hyperoxaluria
- •Hypocitraturic Calcium Oxalate Nephrolithiasis
- •Distal Renal Tubular Acidosis
- •Chronic Diarrheal States
- •Thiazide-Induced Hypocitraturia
- •Idiopathic Hypocitraturic Calcium Oxalate Nephrolithiasis
- •Hypomagnesiuric Calcium Nephrolithiasis
- •Gouty Diathesis
- •Cystinuria
- •Infection Lithiasis
- •Summary
- •References
- •12: Molecular Biology for Urologists
- •Introduction
- •Inherited Changes in Cancer Cells
- •VEGR and Cell Signaling
- •Targeting mTOR
- •Conclusion
- •References
- •13: Chemotherapeutic Agents for Urologic Oncology
- •Introduction
- •Bladder Cancer
- •Muscle Invasive Bladder Cancer
- •Metastatic Bladder Cancer
- •Conclusion
- •Prostate Cancer
- •Other Chemotherapeutic Drugs or Combinations for Treating HRPC
- •Conclusion
- •Renal Cell Carcinoma
- •Chemotherapy
- •Immunotherapy
- •Angiogenesis Inhibitor Drugs
- •Conclusion
- •Testicular Cancer
- •Stage I Seminoma
- •Stage I non-seminomatous Germ Cell Tumours (NSGCT)
- •Metastatic Germ Cell Tumours
- •Low-Volume Metastatic Disease (Stage II A/B)
- •Advanced Metastatic Disease
- •Salvage Chemotherapy for Relapsed or Refractory Disease
- •Conclusion
- •Penile Cancer
- •Side Effects of Chemotherapy
- •Conclusion
- •References
- •14: Tumor and Transplant Immunology
- •Antibodies
- •Cytotoxic and T-helper Cells
- •Immunosuppression
- •Induction Therapy
- •Maintenance Therapy
- •Rejection
- •Posttransplant Lymphoproliferative Disease
- •Summary
- •References
- •15: Pathophysiology of Renal Obstruction
- •Causes of Renal Obstruction
- •Effects on Prenatal Development
- •Prenatal Hydronephrosis
- •Spectrum of Renal Abnormalities
- •Renal Functional Changes
- •Renal Growth/Counterbalance
- •Vascular Changes
- •Inflammatory Mediators
- •Glomerular Development Changes
- •Mechanical Stretch of Renal Tubules
- •Unilateral Versus Bilateral
- •Limitations of Animal Models
- •Future Research
- •Issues in Patient Management
- •Diagnostic Imaging
- •Ultrasound
- •Intravenous Urography
- •Antegrade Urography and the Whitaker Test
- •Nuclear Renography
- •Computed Tomography
- •Magnetic Resonance Urography
- •Hypertension
- •Postobstructive Diuresis
- •References
- •Introduction
- •The Normal Lower Urinary Tract
- •Anatomy
- •Storage Function
- •Voiding Function
- •Neural Control
- •Symptoms
- •Flow Rate and Post-void Residual
- •Voiding Cystometry
- •Male
- •Female
- •Neurourology
- •Conclusions
- •References
- •17: Urologic Endocrinology
- •The Testis
- •Normal Androgen Metabolism
- •Epidemiological Aspects
- •Prostate
- •Brain
- •Muscle Mass and Adipose Tissue
- •Bones
- •Ematopoiesis
- •Metabolism
- •Cardiovascular System
- •Clinical Assessment
- •Biochemical Assessment
- •Treatment Modalities
- •Oral Preparations
- •Parenteral Preparations
- •Transdermal Preparations
- •Side Effects and Treatment Monitoring
- •Body Composition
- •Cognitive Decline
- •Bone Metabolism
- •The Kidneys
- •Endocrine Functions of the Kidney
- •Erythropoietin
- •Calcitriol
- •Renin
- •Paraneoplastic Syndromes
- •Hypercalcemia
- •Hypertension
- •Polycythemia
- •Other Endocrine Abnormalities
- •References
- •General Physiology
- •Prostate Innervation
- •Summary
- •References
- •Wound Healing
- •Inflammation
- •Proliferation
- •Remodeling
- •Principles of Plastic Surgery
- •Tissue Characteristics
- •Grafts
- •Flap
- •References
- •Lower Urinary Tract Symptoms
- •Storage Phase
- •Voiding Phase
- •Return to Storage Phase
- •Urodynamic Parameters
- •Urodynamic Techniques
- •Volume Voided Charts
- •Pad Testing
- •Typical Test Schedule
- •Uroflowmetry
- •Post Voiding Residual
- •Further Diagnostic Evaluation of Patients
- •Cystometry with or Without Video
- •Cystometry
- •Videocystometrography (Cystometry + Cystourethrography)
- •Cystometric Findings
- •Comment:
- •Measurements During the Storage Phase:
- •Measurements During the Voiding Phase:
- •Abnormal Function
- •Disorders of Sensation
- •Causes of Hypersensitive Bladder Sensation
- •Causes of Hyposensitive Bladder Sensation
- •Disorders of Detrusor Motor Function
- •Bladder Outflow Tract Dysfunction
- •Detrusor–Urethral Dyssynergia
- •Detrusor–Bladder Neck Dyssynergia
- •Detrusor–Sphincter Dyssynergia
- •Complex Urodynamic Investigation
- •Urethral Pressure Measurement
- •Technique
- •Neurophysiological Evaluation
- •Conclusion
- •References
- •Endoscopy
- •Cystourethroscopy
- •Ureteroscopy and Ureteropyeloscopy
- •Nephroscopy
- •Virtual Reality Simulators
- •Lasers
- •Clinical Application of Lasers
- •Condylomata Acuminata
- •Urolithiasis
- •Benign Prostatic Hyperplasia
- •Ureteral and Urethral Strictures
- •Conclusion
- •References
- •Introduction
- •The Prostatitis Syndromes
- •The Scope of the Problem
- •Category III CP/CPPS
- •The Goal of Treatment
- •Conservative Management
- •Drug Therapy
- •Antibiotics
- •Anti-inflammatories
- •Alpha blockers
- •Hormone Therapies
- •Phytotherapies
- •Analgesics, muscle relaxants and neuromodulators
- •Surgery
- •A Practical Management Plan
- •References
- •Orchitis
- •Definition and Etiology
- •Clinical Signs and Symptoms
- •Diagnostic Evaluation
- •Treatment of Infectious Orchitis
- •Epididymitis
- •Definition and Etiology
- •Clinical Signs and Symptoms
- •Diagnostic Evaluation of Epididymitis
- •Treatment of Acute Epididymitis
- •Treatment of Chronic Epididymitis
- •Treatment of Spermatic Cord Torsion
- •Fournier’s Gangrene
- •Definition and Etiology
- •Risk Factors
- •Clinical Signs and Symptoms
- •Diagnostic Evaluation
- •Treatment
- •References
- •Fungal Infections
- •Candidiasis
- •Aspergillosis
- •Cryptococcosis
- •Blastomycosis
- •Coccidioidomycosis
- •Histoplasmosis
- •Radiographic Findings
- •Treatment
- •Tuberculosis
- •Clinical Manifestations
- •Diagnosis
- •Treatment
- •Schistosomiasis
- •Clinical Manifestations
- •Diagnosis
- •Treatment
- •Filariasis
- •Clinical Manifestations
- •Diagnosis
- •Treatment
- •Onchocerciasis
- •References
- •25: Sexually Transmitted Infections
- •Introduction
- •STIs Associated with Genital Ulcers
- •Herpes Simplex Virus
- •Diagnosis
- •Treatment
- •Chancroid
- •Diagnosis
- •Treatment
- •Syphilis
- •Diagnosis
- •Treatment
- •Lymphogranuloma Venereum
- •Diagnosis
- •Treatment
- •Chlamydia
- •Diagnosis
- •Treatment
- •Gonorrhea
- •Diagnosis
- •Treatment
- •Trichomoniasis
- •Diagnosis
- •Treatment
- •Human Papilloma Virus
- •Diagnosis
- •Treatment
- •Scabies
- •Diagnosis
- •Treatment
- •References
- •26: Hematuria: Evaluation and Management
- •Introduction
- •Classification of Hematuria
- •Macroscopic Hematuria
- •Microscopic Hematuria
- •Dipstick Hematuria
- •Pseudohematuria
- •Factitious Hematuria
- •Menstruation
- •Aetiology
- •Malignancy
- •Urinary Calculi
- •Infection and Inflammation
- •Benign Prostatic Hyperplasia
- •Trauma
- •Drugs
- •Nephrological Causes
- •Assessment
- •History
- •Examination
- •Investigations
- •Dipstick Urinalysis
- •Cytology
- •Molecular Tests
- •Blood Tests
- •Flexible Cystoscopy
- •Upper Urinary Tract Evaluation
- •Renal USS
- •KUB Abdominal X-Ray
- •Intravenous Urography (IVU)
- •Computed Tomography (CT)
- •Retrograde Urogram Studies
- •Magnetic Resonance Imaging (MRI)
- •Additional Tests and Renal Biopsy
- •Intractable Hematuria
- •Loin Pain Hematuria Syndrome
- •References
- •27: Benign Prostatic Hyperplasia (BPH)
- •Historical Background
- •Pathophysiology
- •Patient Assessment
- •Treatment of BPH
- •Watchful Waiting
- •Drug Therapy
- •Interventional Therapies
- •Conclusions
- •References
- •28: Practical Guidelines for the Treatment of Erectile Dysfunction and Peyronie´s Disease
- •Erectile Dysfunction
- •Introduction
- •Diagnosis
- •Basic Evaluation
- •Cardiovascular System and Sexual Activity
- •Optional Tests
- •Treatment
- •Medical Treatment
- •Oral Agents
- •Phosphodiesterase Type 5 (PDE 5) Inhibitors
- •Nonresponders to PDE5 Inhibitors
- •Apomorphine SL
- •Yohimbine
- •Intracavernosal and Intraurethral Therapy
- •Intracavernosal Injection (ICI) Therapy
- •Intraurethral Therapy
- •Vacuum Constriction Devices
- •Surgical Therapy
- •Conclusion
- •Peyronie´s Disease (PD)
- •Introduction
- •Oral Drug Therapy
- •Intralesional Drug Therapy
- •Iontophoresis
- •Radiation Therapy
- •Surgical Therapy
- •References
- •29: Premature Ejaculation
- •Introduction
- •Epidemiology
- •Defining Premature Ejaculation
- •Voluntary Control
- •Sexual Satisfaction
- •Distress
- •Psychosexual Counseling
- •Pharmacological Treatment
- •On-Demand Treatment with Tramadol
- •Topical Anesthetics
- •Phosphodiesterase Inhibitors
- •Surgery
- •Conclusion
- •References
- •30: The Role of Interventional Management for Urinary Tract Calculi
- •Contraindications to ESWL
- •Complications of ESWL
- •PCNL Access
- •Instrumentation for PCNL
- •Nephrostomy Drains Post PCNL
- •Contraindications to PCNL
- •Complications of PCNL
- •Semirigid Ureteroscopy
- •Flexible Ureteroscopy
- •Electrohydraulic Lithotripsy (EHL)
- •Ultrasound
- •Ballistic Lithotripsy
- •Laser Lithotripsy
- •Ureteric Stents
- •Staghorn Calculi
- •Lower Pole Stones
- •Horseshoe Kidneys and Stones
- •Calyceal Diverticula Stones
- •Stones and PUJ Obstruction
- •Treatment of Ureteric Colic
- •Medical Expulsive Therapy (MET)
- •Intervention for Ureteric Stones
- •Stones in Pregnancy
- •Morbid Obesity
- •References
- •Anatomy and Function
- •Pathophysiology
- •Management
- •Optical Urethrotomy/Dilatation
- •Urethral Stents
- •Preoperative Assessment
- •Urethroplasty
- •Anastomotic Urethroplasty
- •Substitution Urethroplasty
- •Grafts Versus Flaps
- •Oral Mucosal Grafts
- •Tissue Engineering
- •Graft Position
- •Conclusion
- •References
- •32: Urinary Incontinence
- •Epidemiology and Risk Factors
- •Pathophysiology
- •Urge Incontinence
- •Conservative Treatments
- •Pharmacotherapy
- •Invasive/ Surgical Therapies
- •Stress Urinary Incontinence
- •Male SUI Therapies
- •Female SUI Therapies
- •Mixed Urinary Incontinence
- •Conclusions
- •References
- •33: Neurogenic Bladder
- •Introduction
- •Examination and Diagnostic Tests
- •History and Physical Examination
- •Imaging
- •Urodynamics (UDS)
- •Evoked Potentials
- •Classifications
- •Somatic Pathways
- •Brain Lesions
- •Cerebrovascular Accident (CVA)
- •Parkinson’s Disease (PD)
- •Multiple Sclerosis
- •Huntington’s Disease
- •Dementias
- •Normal Pressure Hydrocephalus (NPH)
- •Tumors
- •Psychiatric Disorders
- •Spinal Lesions and Pathology
- •Intervertebral Disk Prolapse
- •Spinal Cord Injury (SCI)
- •Transverse Myelitis
- •Peripheral Neuropathies
- •Metabolic Neuropathies
- •Pelvic Surgery
- •Treatment
- •Summary
- •References
- •34: Pelvic Prolapse
- •Introduction
- •Epidemiology
- •Anatomy and Pathophysiology
- •Evaluation and Diagnosis
- •Outcome Measures
- •Imaging
- •Urodynamics
- •Indications for Management
- •Biosynthetics
- •Surgical Management
- •Anterior Compartment Repair
- •Uterine/Apical Prolapse
- •Enterocele Repair
- •Conclusion
- •References
- •35: Urinary Tract Fistula
- •Introduction
- •Urogynecologic Fistula
- •Vesicovaginal Fistula
- •Etiology and Risk Factors
- •Clinical Factors
- •Evaluation and Diagnosis
- •Pelvic Examination
- •Cystoscopy
- •Imaging
- •Treatment
- •Conservative Management
- •Surgical Management
- •Urethrovaginal Fistula
- •Etiology and Presentation
- •Diagnosis and Management
- •Ureterovaginal Fistula
- •Etiology and Presentation
- •Diagnosis and Management
- •Vesicouterine Fistula
- •Etiology and Presentation
- •Diagnosis and Management
- •Uro-Enteric Fistula
- •Vesicoenteric Fistula
- •Pyeloenteric Fistula
- •Urethrorectal Fistula
- •References
- •36: Urologic Trauma
- •Introduction
- •Kidney
- •Expectant Management
- •Endovascular Therapy
- •Operative Intervention
- •Operative Management: Follow-up
- •Reno-Vascular Injuries
- •Pediatric Renal Injuries
- •Adrenal
- •Ureter
- •Diagnosis
- •Treatment
- •Delayed Diagnosis
- •Bladder and Posterior Urethra
- •Bladder Injuries: Initial Management
- •Bladder Injuries: Formal Repair
- •Anterior Urethral Trauma
- •Fractured Penis
- •Penile Amputation
- •Scrotal and Testicular Trauma
- •Imaging
- •CT-IVP (CT with Delayed Images)
- •Technique
- •Cystogram
- •Technique
- •Retrograde Urethrogram (RUG)
- •Technique
- •Retrograde Pyelogram (RPG)
- •Technique
- •One-Shot IVP
- •Technique
- •References
- •37: Bladder Cancer
- •Who Should Be Investigated?
- •Epidemiology
- •Risk Factors
- •Role of Screening
- •Signs and Symptoms
- •Imaging
- •Cystoscopy
- •Urine Tests
- •PDD-Assisted TUR
- •Pathology
- •NMIBC and Risk Groups
- •Intravesical Chemotherapy
- •Intravesical Immunotherapy
- •Immediate Cystectomy and CIS
- •Radical Cystectomy with Pelvic Lymph Node Dissection
- •sexual function-preserving techniques
- •Bladder-Preservation Treatments
- •Neoadjuvant Chemotherapy
- •Adjuvant Chemotherapy
- •Preoperative Radiotherapy
- •Follow-up After TUR in NMIBC
- •References
- •38: Prostate Cancer
- •Introduction
- •Epidemiology
- •Race
- •Geographic Variation
- •Risk Factors and Prevention
- •Family History
- •Diet and Lifestyle
- •Prevention
- •Screening and Diagnosis
- •Current Screening Recommendations
- •Biopsy
- •Pathology
- •Prognosis
- •Treatment of Prostate Cancer
- •Treatment for Localized Prostate Cancer (T1, T2)
- •Radical Prostatectomy
- •EBRT
- •IMRT
- •Brachytherapy
- •Treatment for Locally Advanced Prostate Cancer (T3, T4)
- •EBRT with ADT
- •Radical Prostatectomy
- •Androgen-Deprivation Therapy
- •Summary
- •References
- •39: The Management of Testis Cancer
- •Presentation and Diagnosis
- •Serum Tumor Markers
- •Primary Surgery
- •Testis Preserving Surgery
- •Risk Stratification
- •Surveillance Versus Primary RPLND
- •Primary RPLND
- •Adjuvant Treatment for High Risk
- •Clinical Stage 1 Seminoma
- •Risk-Stratified Adjuvant Treatment
- •Adjuvant Radiotherapy
- •Adjuvant Low Dose Chemotherapy
- •Primary Combination Chemotherapy
- •Late Toxicity
- •Salvage Strategies
- •Conclusion
- •References
- •Index
34
Pelvic Prolapse
Rashel M. Haverkorn and Philippe E. Zimmern
Introduction
Pelvic organ prolapse is a condition in which the pelvic organs are displaced and they protrude by varying degrees into the vaginal canal (ACOG). Affected organs can include the urethra, bladder, rectum, small bowel, uterus, or more commonly, a combination of these pelvic organs. Approximately, 300,000 prolapse surgeries are performed annually in the United States, with an estimated cost of over $1 billion.1 Several series have estimated that approximately 30–40% of women develop pelvic organ pro- lapse,2-4 and the lifetime estimate of surgical risk reaches 11–12% by 80 years of age.5,6
In the last few years, this rapidly progressing field has benefited from large-scale studies conducted worldwide, and notably in the United States by the accomplishments of the Pelvic Floor Disease Network (PFDN) of the National Institutes of Health (NIH). Because recurrence is unfortunately common after corrective surgery, with rates approaching 30%, many new techniques using a variety of reinforcing meshes have emerged.5 A recent FDA warning (October 2008) has reminded patients and physicians alike in cautiously employing mesh until adequate safety and efficacy records are established in randomized trials. While techniques of vaginal repair continue to evolve, newer advances in minimally invasive procedures have become increasingly used widely, with the most recent introduction being the robot. This chapter
highlights current areas of controversies and the practical progresses made recently in the field of POP with an emphasis on clinical diagnosis and surgical repair.
Epidemiology
Many factors have been identified as contributing to the development of pelvic organ prolapse, including parity, race, and age (Fig. 34.1). Other medical conditions which are associated with abdominal straining, such as chronic obstructive pulmonary disease and chronic constipation or diseases with connective tissue abnormalities, such as Ehler–Danlos syndrome and Marfan’s disease, can lead to greater risk of prolapse.
Prolapse in African American women is less common, while Hispanic females seem to have the highest risk for uterine prolapse.8 Asian American women are found to have the highest rates of anterior and posterior compartment prolapse. A nationwide concern, the trend in obese and overweight adults is increasing. Not only has weight been associated with development of both urge and stress incontinence, but overweight and obese females have been found to have higher risks of prolapse progression as well. Whereas weight loss has been associated with improvement in incontinence, this has not been demonstrated to be true with pelvic organ prolapse.2,11 Family history plays an important
C.R. Chapple and W.D. Steers (eds.), Practical Urology: Essential Principles and Practice, |
465 |
DOI: 10.1007/978-1-84882-034-0_34, © Springer-Verlag London Limited 2011 |
|
466
Practical Urology: EssEntial PrinciPlEs and PracticE
Figure 34.1. Model for the develop ment of pelvic floor dysfunction in women (reprinted from Bump and norton7. copyright 1998.With permission from Elsevier).
|
|
Incite |
|
Promote |
|
|
|
|
Constipation |
||
Predispose |
|
Childbirth |
|
||
|
|
Occupation |
|||
Gender racial |
|
Nerve damage |
|
||
|
|
Recreation |
|||
Neurologic |
|
Muscle damage |
|
||
|
|
Obesity |
|||
Anatomic |
|
Radiation |
|
||
|
|
Surgery |
|||
Collagen |
|
Tissue disruption |
|
||
|
|
Lung disease |
|||
Muscular |
|
Radical surgery |
|
||
|
|
Smoking |
|||
Cultural |
|
|
|
||
|
|
|
Menstrual cycle |
||
Environmental |
|
|
|
||
|
|
|
Infection |
||
|
|
|
|
||
|
|
|
|
Medications |
|
|
|
Normal support |
|
Menopause |
|
|
|
|
|
|
|
|
|
or function |
|
|
|
|
|
|
|
|
|
Intervene |
|
Decompensate |
|
Aging |
|
Behavioral |
Abnormal |
|
Pharmacologic |
support |
Dementia |
Devices |
or function |
Debility |
Surgical |
|
Disease |
|
|
Environment |
|
|
Medications |
role in many diseases. Positive family history for prolapse was noted in 78% of patients with severe prolapse and 50% of patients with mild prolapse in a study of patients presenting for routine gynecologic care.12 However, a Swedish twin study examining for the presence of genetic factors in the development of stress incontinence and prolapse noted that genetics may have a contributory role, but that environmental factors remain a strong determinant in the development of prolapse.13 Occupation may also play a role in prolapse. Several studies have found an association between lower income and less education, with laborers and factory workers having high incidence of severe pelvic organ prolapse.14 Prior surgery also plays a role with patients having had a previous hysterectomy, particularly by vaginal approach, or prolapse repair at greater risk for developing prolapse.15
The strongest associations have been found with advancing age and increased parity. Higher parity confers an 11-fold greater risk in the development of prolapse.16 Larger babies and number of vaginal deliveries contributed greatly to the presence of prolapse.3,17 These changes are suspected to be the result of the trauma that occurs during childbirth, characterized by pudendal nerve injury and injury to the muscles, tissues, and nerves of the pelvic floor and perineal body.
Anatomy and Pathophysiology
The pelvic cavity can be divided into anterior, posterior, and apical compartments with respect to the uterus and vagina. The support of the pelvic organs is a result of a combination of the pelvic floor musculature, fascial supports, and suspensory ligaments. The fascial supports and suspensory ligaments are condensations of peritoneum and connective tissues that attach the uterus, cervix, vagina, and urethra at different locations to the fascia of the pelvic sidewall and sacrum, thereby providing distinct levels of support (Fig. 34.2). The uterosacral and cardinal ligaments insert onto the cervix and upper vagina, comprising support at Level I. These ligaments prevent downward descent of the uterus and cervix and are responsible for apical support after hysterectomy. Tears or weakness in Level I support can result in uterine descent or vaginal vault prolapse and apical enterocele. Level II support is comprised of fascial attachments inserting on the midportion of the vagina and urethra, which extend laterally to the obturator internus fascia of the pelvic sidewall at the white line, or arcus tendineus fascia pelvis (ATFP). The lower vagina and urethral tissues are directly attached to surrounding structures, including the perineal body and rectovaginal septum, as Level III support. A defect in Level II or III support results in anterior and/or posterior vaginal wall prolapse, clinically
467
PElvic ProlaPsE
III II I
Ischial spine & sacrospinous ligament
Levator ani
Pubocervical fascia Rectovaginal fascia
weakness and increased flexibility of pelvic tissues, thereby predisposing to prolapse.20,21 Additionally, lower elastin expression and altered synthesis has been seen in the vaginal epithelium and uterosacral ligaments.22,23 Bioengineering of frozen/thawed and fresh vaginal tissues now permits to better understand the deformation of these aging tissues compared to age-comparable controls and to design finite element models of the vaginal wall from which newer reinforcing tissues (biocompatible mesh, tissue engineering) will be developed.24-26
Evaluation and Diagnosis
Figure 34.2. levels of vaginal support (reprinted from delancey et al.18 With permission from Elsevier).
evident as cystocele, rectocele, posterior enterocele, or a combination. The endopelvic fascia and levator ani muscles insert on the perineal body, lifting and supporting the rectum. Detachment or weakness here will produce a mobile and bulging perineum with straining,termed perineocele. Straining can widen the genital hiatus, further decreasing support to the anterior, posterior, and apical compartments, thereby worsening the degree of concomitant prolapse.
The biomechanical properties of connective tissue play an important role in determining the strength of the supporting ligaments and fascia. Smooth muscle, collagen, and elastin are components of connective tissue that impart strength and flexibility to the pelvic fascia and musculature, allowing for changes during pregnancy and childbirth. Dysfunction and alteration of these components are suspected to be contributing factors in the development of prolapse. Surgical biopsies of vaginal epithelium from patients with prolapse have been found to have significantly decreased amounts of smooth muscle in the muscularis layer with increased rates of apoptosis when compared to patients without prolapse.19 The tensile strength of tissues is the result of its collagen content, with type I collagen primarily responsible for strength and type III collagen responsible for elasticity of the tissues. Alterations in the amount and structure of collagen or in the ratio of types of collagen in pelvic and vaginal tissues account for the
Women with prolapse may complain of a variety of symptoms, including vaginal pressure or fullness, lower back or abdominal pain, incomplete emptying or urinary retention, stress incontinence, constipation or fecal incontinence. Patients with severe pelvic organ prolapse may complain of a vaginal bulge or feeling that something is “falling out” of the vagina. There is no consistent correlation between prolapse symptoms and physical exam findings, other than prolapse 0.5 cm or more beyong the hymen is strongly correlated with bulging symptoms.27
The two most employed systems for clinical examination and grading prolapse are the BadenWalker “half-way” system and the Pelvic Organ Prolapse Quantification (POP-Q). In recent literature, as a result of attempting to reproduce and standardize prolapse grade, the POP-Q has become the predominant grading system. It is a complex system that can be initially challenging to incorporate into practice,but provides detailed information about each compartment that can be useful in patient follow-up.
The Baden-Walker half-way scoring system was introduced in 1972 and consists of a series of stages to quantify vaginal prolapse. It is easy to learn and use, and has good interexaminer reliability. The maximal protruding segment is measured during straining or standing with the reference point being the hymen.
Stage I: the cervix, vaginal apex, anterior or posterior bladder wall descends half-way to the hymen.
Stage II: the cervix, vaginal apex, anterior bladder or posterior wall extends to the lower vagina, but not beyond the hymen.
Stage III: the cervix, vaginal vault, anterior or posteriorbladderwallextendbeyondthehymen, but is less than half-way completely prolapsed.
Stage IV: the cervix, vaginal vault, anterior or posterior bladder wall extend beyond the hymen, and is more than half-way completely prolapsed.
The Pelvic Organ Prolapse Quantification (POP- Q) system was developed by the International Continence Society (ICS) as an international tool to objectively describe, quantify, and stage pelvic support in women.28 It divides the vagina into six regions or points measured in centimeters with the reference point being the hymenal ring, consistent and easily identifiable structure that is assigned a measurement of 0. Measurements that are proximal to the hymen are distinguished by negative numbers; likewise, measurements that are distal to the hymen are given positive numbers.Additionally, the genital hiatus, the perineal body, and the total vaginal length are measured to complete the nine points of the system (Figs. 34.3 and 34.4).
Aa: a point in the midline of the anterior vaginal wall that is 3 cm from the hymen
Ba: the point on the anterior vaginal wall which represents the most dependent or prolapsed segment
D
3 cm |
Ba |
C |
Aa
Bp
Ap
TVL
GH
PB
Figure 34.3. Pelvic organ prolapse quantification (PoPQ) scheme.six points (aa,ap,Ba,Bp,c,and d) are labeled.gH repre sents the genital hiatus, PB represents the length of the perineal body, and tvl represents the total vaginal length (reprinted from Bump et al.28 copyright 1996. With permission from Elsevier).
468
Practical Urology: EssEntial PrinciPlEs and PracticE
Figure 34.4. vaginal vault prolapse (complete eversion). according to the PoPQ classification, aa (point in the midline of the anterior vaginal wall that is 3 cm from the hymen) is approxi mately 3 cm beyond the hymen.ap (a point in the midline of the posterior vaginal wall that is 3 cm from the hymen) is also 3 cm beyond the hymen.Point c (the point which represents the most distal surface of the cervix or the vaginal cuff) is approximately 9 cm beyond the hymen. Because point c also represents the most distal prolapsed segments of the anterior and posterior vaginal walls, points Ba and Bp are also assigned values of +9.
Ap: a point in the midline of the posterior vaginal wall that is 3 cm from the hymen
Bp: the point on the posterior vaginal wall which represents the most dependent or prolapsed segment
C:the point which represents the most distal surface of the cervix or the vaginal cuff
D:the point which represents the posterior fornix, omitted if the cervix is absent
GH: measured from the external urethral meatus to the midpoint of the posterior hymenal ring
PB: measured from the midpoint of the posterior hymenal ring to the midpoint of the anus TVL: measured from the hymen to the cervix or vaginal apex in a reduced state